Integrated Superintelligent Technology
Proprietary closed-source protein design models with performance on par with SOTA open-source models. Ascend C operator optimization and hardware-software co-design deliver superior inference speed.
ToursynClaw: Superintelligent Agents for Protein Design
Collaborative AI agent for protein scientists that leverages natural-language interaction to complete the entire workflow - from target analysis to wet-lab experiments - in one place.
Try NowToursynClaw: Scientific Superintelligence Focused on Biopharma R&D
ToursynClaw is our proprietary AI protein design platform integrating 20+ specialized models across target analysis, structure prediction, molecular generation, performance evaluation, and candidate selection to accelerate innovative biologic discovery and development.
Scientific Superintelligence Agents
Its core technology centers on AI-driven protein design, and it has built multiple proprietary platforms and models at world-leading levels with superior integrated performance.
Proprietary Closed - Source Protein Design Model
Dry-Wet Integrated Superintelligence lab
AI Scientist Agent
Autonomously designs experiments, proposes AI solutions, and automates data processing and model training. Interacts independently with wet-lab agents and updates iteratively every 3 days.
Antibody Testing Agent
Fully automatically builds plasmids and proteins from amino-acid sequences recommended by the AI platform and returns high-throughput test results in 11 days.
De novo Design
Indication: CLDN18.2-Positive Solid Tumors
CLDN18.2 is a clinically validated therapeutic target primarily associated with gastric cancer and gastroesophageal junction adenocarcinoma, with potential applications in pancreatic cancer and other CLDN18.2-positive solid tumors.
Claudin-18.2
- 1
- Month Timeline
- 30
- Designed Antibodies
- 2
- Functional Hits
- 8nM
- Best Binding Affinity
